Registration Now Open for BOS Events 2024!

Bio2Business Ltd is delighted to open registration for BOS Events 2024 which includes: BOS Basel 2024, which will take place on the 19th and 20th of June at Congress Centre Basel; and BOS Manchester 2024, which will take place on the 26th and 27th of November at Manchester Central.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for virtual events during 2024. We look forward to welcoming you and your colleagues to BOS Events 2024! Please contact the Bio2Business team for further details.

Follow us on LinkedIn to see our latest announcements


Featured Company (BOS Manchester 2024)

Logo for Almac Group
Almac Group
Almac Group, an established CDMO, provides a unique range of integrated drug development services to the pharmaceutical and biotech industry. Our quality, innovation and efficiency are why over 600 companies worldwide trust Almac to support their clinical trials and ultimately commercialisation. Our...
View profile

Featured Speaker (BOS Basel 2024)

photo of Dr Dr Adam Patterson

A Novel Series of Ivosidenib-Polymer Cocrystals

Dr Adam Patterson, Senior Scientist I, Veranova

ABSTRACT: Novel series of Ivosidenib-Polymer cocrystals - Oral presentation by Adam R. Patterson, Veranova (Cambridge, UK)
Pharmaceutical salts are a ubiquitous front-line approach to improve the inherent low aqueous solubility of increasingly complex small molecules where an ionisable group is present. Within pharmaceuticals, cocrystals have been increasingly investigated and found wider regulatory acceptance in the prior two decades and their formation can provide a viable alternative to improve aqueous solubility and tune solid form properties of non-ionisable active molecules. We argue that cocrystallisation... Click here to Read More